Hematologic toxicity from bleomycin in advanced cancer patients.
D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D001761:Bleomycin